Resolve Biosciences raises €21.6M Series A round
10 December 2020· Monheim am Rhein, Germany· health, biotech, ai, b2b, software_hardware
The company emerged from stealth with this funding to accelerate product development and drive industry adoption of its spatial multiomics analysis platform.
Investors
LeadPS Capital Management
Also participating
High-Tech GründerfondsAlafi CapitalMasterMind Advisory ServicesJohn Shoffner
About Resolve Biosciences
Stage
Series B
Headquarters
Monheim am Rhein, Germany
Founded
2020
Team Size
51–200
Sectors
healthbiotechaib2bsoftware_hardware